Genomic Classification and Prognosis in Acute Myeloid LeukemiaElli Papaemmanuil, Peter J. Campbell, Moritz Gerstung et al.|New England Journal of Medicine|2016Cited by 4.4k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working PartyMichael Heuser, Jacqueline Cloos, Sylvie Freeman et al.|Blood|2021Cited by 714
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Alexandra Smith, Juan E. Arango et al.|Nature Medicine|2020Cited by 633
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failureMohammed Wattad, Daniela Weber, Konstanze Döhner et al.|Leukemia|2017Cited by 118
Gemtuzumab Ozogamicin in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III StudyRichard F. Schlenk, Hartmut Döhner, Peter Paschka et al.|Journal of Clinical Oncology|2019Cited by 111